OpenCompanies

Orchid Cellmark Ltd

Company number
04045527
Status
Active
Type
Private Limited Company
Incorporated
28 Jul 2000
Nature of business
Technical testing and analysis

Registered office

Unit G1 Valiant Way
I54 Business Park
Wolverhampton
WV9 5GB

Previous names

  • Orchid Biosciences Europe Limited (until 3 Nov 2005)

Officers

NameRoleAppointedResigned
SWIFT INCORPORATIONS LIMITED Corporate-Nominee-Secretary 28 Jul 2000 28 Jul 2000
INSTANT COMPANIES LIMITED Corporate-Nominee-Director 28 Jul 2000 28 Jul 2000
ASHTON, Christopher Philip Director 5 Sep 2000 24 Sep 2002
MARVIN, Donald Ray Secretary 28 Jul 2000 29 Sep 2002
PFOST, Dale Director 28 Jul 2000 9 Dec 2002
MARVIN, Donald Ray Director 28 Jul 2000 31 Jan 2003
SAVADELIS, Andrew Secretary 29 Sep 2002 7 Jul 2003
SAVADELIS, Andrew Director 29 Sep 2002 7 Jul 2003
SPICER, Michael Secretary 9 Jul 2003 31 Dec 2004
SPICER, Michael Director 9 Jul 2003 31 Dec 2004
VITTY, Graham John Director 29 Sep 2002 28 Oct 2005
LAND, Raymond Director 6 Jun 2005 1 Sep 2006
KELLY, Paul Director 9 Jul 2003 1 Sep 2006
MELTZER, Warrent., Vice President And General Counsel Secretary 8 Mar 2005 4 Mar 2007
MELTZER, Warrent., Vice President And General Counsel Director 8 Mar 2005 4 Mar 2007
FOX, Mark Wilson, Finance Director Director 15 Dec 2005 26 Oct 2008
BOLOGNA, Thomas Secretary 4 Mar 2007 16 Dec 2011
BOLOGNA, Thomas Director 4 Mar 2007 16 Dec 2011
DERBYSHIRE, Roger Bernard Director 9 Dec 2008 30 Apr 2017
PRINGLE, Robert Stewart Director 12 May 2017 7 Aug 2018
SISEC LIMITED Corporate-Secretary 6 Aug 2012 7 Aug 2018
EBERTS III, Floyd Samuel Director 7 Jun 2012 7 Aug 2018
HARTSHORNE, David John Director 2 Dec 2008 20 Aug 2024
VAN DORP, Rob Director 20 Aug 2024 18 Mar 2025
CARNAGHAN, Mark Lindesay Director 1 Jul 2025
GANDERTON, Laura Jayne Secretary 20 Aug 2024
PEARSE, Mark Laurence Director 20 Aug 2024
NELSON, Andrew David Director 20 Aug 2024

Control

NameNature of controlNotifiedCeased
Laboratory Corporation Of America Holdings Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors		 6 Apr 2016 7 Aug 2018
Dnaco Ownership Of Shares 75 To 100 Percent 7 Aug 2018 16 Apr 2025
Eurofins Scientific S.E. Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors		 16 Apr 2025

Accounts

Year ended Turnover Net assets Cash Employees
31 Dec 2024 £33,104,000 -£5,866,000 £335,000 554000
31 Dec 2023 £31,827,000 -£2,855,000 £157,000 539000
31 Dec 2022 £28,192,000 -£354,000 £157,000 528000
31 Dec 2021 £30,115,000 £6,133,000 £1,144,000 506000
31 Dec 2020 £28,900,000 £7,247,000 £2,184,000 490000
31 Dec 2019 - - - -
31 Dec 2018 - - - -
31 Dec 2017 - - - -
31 Dec 2016 - - - -
31 Dec 2015 - - - -
31 Dec 2014 - - - -
31 Dec 2013 - - - -
31 Dec 2012 - - - -
31 Dec 2011 - - - -
31 Dec 2010 - - - -
31 Dec 2009 - - - -
31 Dec 2008 - - - -
31 Dec 2007 - - - -
31 Dec 2006 - - - -
31 Dec 2005 - - - -
31 Dec 2004 - - - -
31 Dec 2003 - - - -
31 Dec 2002 - - - -
31 Dec 2001 - - - -

Connections

Controls

Directors’ other companies

Companies at the same address

Data